Consensus Papers, Manuscripts, Abstracts for Congresses, other publications

End-to-End Evidence & Publication Services

MphaR Our Services Consensus Papers, Manuscripts, Abstracts for Congresses, other publications

Consensus Papers, Manuscripts, Literature Reviews, Systematic Reviews, Abstracts for Congresses, Other Publications

MphaR delivers end-to-end evidence generation and scientific communication services that support your Medical Affairs and clinical strategies. From comprehensive literature reviews to consensus development and high-quality congress abstracts, we ensure that every output is scientifically robust, compliant, and aligned with your strategic objectives. Our expert team—supported by the MphaR Digital Platform—transforms data into clear, credible, and impactful scientific content ready for publication, presentation, or internal decision-making.

Comprehensive Evidence & Publication Solutions

Transforming Expert Insights Into High-Impact Scientific Output

At MphaR, we support Medical Affairs teams in generating high-quality, evidence-based consensus and scientific publications that shape clinical practice and close knowledge gaps. Through our structured methodologies, digital platforms, and global network of experts, we ensure rigorous, unbiased, and efficient development of consensus manuscripts, guidelines, and recommendations. Our approach combines expert engagement, advanced consensus techniques, and streamlined publication management to deliver timely, credible, and practice-changing scientific outputs.

Our approach combines expert engagement, advanced consensus techniques, and streamlined publication management to deliver timely, credible, and practice-changing scientific outputs.

Our Expertise Includes:

Consensus Papers 

Guidelines & Recommendations 

Position Statements 

Delphi & NGT Consensus Projects 

Steering Committee–Led Publications 

Manuscript Drafting & Submission Support 

All projects are supported through the MphaR Digital Platform, enabling seamless asynchronous discussions, secure document review, polling/surveys, and structured collaboration among global experts.

Consensus Methodologies We Use

1. Delphi Methodology

A structured, anonymous, and iterative process used to gather expert input and reach consensus on complex or uncertain issues.

Key characteristics: 
  • Involves a panel of multidisciplinary experts
  • Multiple rounds of questionnaires with feedback
  • Reduces bias, group pressure, and dominance
  • Suitable when no single “right” answer exists
  • Drafting and refining meeting materials (agendas, slides, questions)
  • Ensures robust, data-driven consensus 
Defining the problem → Recruiting experts → Creating questionnaires → Multiple survey rounds → Final consensus & reporting

2. Nominal Group Technique (NGT)

An interactive group-based methodology used when diverse stakeholders must jointly prioritize issues or generate ideas.
Benefits of NGT: 
  • Generates more ideas than traditional open discussions
  • Balances influence among participants
  • Reduces competition and pressure to confirm
  • Encourages constructive problem-solving
  • Enables democratic prioritization
  • Provides stronger closure and clarity of direction

ICMJE Authorship Criteria Compliance

All publication projects follow the International Committee of Medical Journal Editors (ICMJE) requirements, ensuring integrity and scientific credibility.
Advisors and authors must: 
  • Substantially contribute to conception, design, data acquisition/analysis
  • Participate in drafting or critically revising the work
  • Approve the final version
  • Take accountability for accuracy and integrity
  • Drafting and refining meeting materials (agendas, slides, questions)
This reinforces learning and provides valuable insights for future program planning.

Two-Stage Consensus Development Model

Stage 1 — Expert Engagement & Early Insights

  • Expert identification 
  • Steering Committee Meeting (live or virtual)
  • Drafting initial survey or discussion guide
  • Asynchronous discussion on MphaR Platform (multiple choice, open-text, ranking questions)

Stage 2 — Manuscript Development

  • Analysis of expert responses 
  • Draft manuscript prepared and reviewed on the platform
  • Live follow-up discussion if required
  • Submission of consensus-derived manuscript to a peer-reviewed journal

End-to-End Digital Workflow Via the MphaR Platform:

For teams seeking streamlined, centralized collaboration, our MphaR Digital Platform enables:
  • Real-time or asynchronous review
  • Commenting and version control
  • Secure data sharing
  • Faster consensus and approvals
  • Compliance-ready documentation

Examples of Consensus & Publication Projects

Breast Cancer

Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)Development and delivery of scientific education formats, including digital CME, accredited courses, workshops, and symposia.

Joanne Wing Yan Chiu et al.

Drug Safety (2023) 46:927-949

Chronic Lymphocytic Leukemia

International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL
Farrukh T. Awan et al.

Blood Adv (2022) 6 (18): 5516–5525.

Oncology

Implementing precision oncology in Latin America to improve patient outcomes
Eva Maria Ruiz de Castilla et al.

ecancer(2024)

Lung Cancer

Lung Cancer Screening in Asia: An Expert Consensus Report
David Chi-Leung Lam et al.

Journal of Thoracic Oncology (2023) 18 (suppl)

Multiple Myeloma

Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting
Ayman Alhejazi et al.

Clinical Lymphoma, Myeloma and Leukemia, Volume 25, Issue 10, e756 – e765

Multiple Myeloma

Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma
Ghazi S. Alotaibi et al.

Clinical Lymphoma, Myeloma and Leukemia, Volume 25, Issue 12, 851 – 862.e2

Blastic plasmacytoid dendritic cell neoplasm

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Nasir Bakshi et al.

Cancers 2025, 17(2), 221.

Chronic Lymphocytic Leukaemia

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL
Constantine Tam et al

Blood Adv (2023) 7 (22):6819-6828.

Why Partner With MphaR for Consensus & Publications?

 End-to-end project delivery

From expert identification to final manuscript submission.

 Scientific excellence & compliance

All processes align with ICMJE, GPP, and industry standards.

Global reach

Access to diverse, regionally balanced expert panels (HCPs, researchers, PAGs, caregivers).

Digital-enabled efficiency

  • 24/7 asynchronous discussions
  • Secure document review
  • Built-in polls & surveys
  • Standardized data collection
  • Clear audit trails

Faster timelines & lower costs

Compared to traditional in-person models.

Transforming Scientific Data Into High-Impact Congress Abstracts

At MphaR, we support Medical Affairs and Clinical teams in transforming scientific data into clear, compelling, and publication-ready abstracts for major international and regional congresses (ASCO, ESMO, ASH, SABCS, IASLC, ISPOR, and many others). With a focus on scientific accuracy, compliance, and strategic communication, we ensure your research is positioned to achieve maximum visibility and impact.

Our team of experienced Medical Writers, Scientific Advisors, and Publication Specialists manages the full lifecycle of abstract development—from data interpretation to final submission—adhering to congress-specific guidelines and timelines.

MphaR Abstract Development Services Include:

1. Scientific & Strategic Assessment

  • Review and interpretation of study data, insights, or real-world evidence
  • Identification of the most suitable angle and scientific narrative
  • Recommendations on the optimal congress and submission category
  • Alignment with your publication plan and strategic objectives

2. Abstract Writing & Scientific Messaging

  • Full development of structured or unstructured abstracts
  • Clear, concise, and congress-compliant scientific language
  • Highlighting clinical relevance, innovation, and value proposition
  • Ensuring alignment with scientific communication strategy

3. Compliance & Authorship Management

  • Full adherence to congress formatting requirements
  • Compliance with ICMJE and Good Publication Practice (GPP)
  • Authorship coordination and approval workflows
  • Review management with cross-functional teams

4. Data Visualization & Supportive Materials

  • Creation of congress-ready figures, tables, and visuals
  • Formatting according to congress technical specifications
  • Optional: preparation of extended data summaries or supplementary files

5. Submission & Post-Submission Support

  • Complete submission via congress portals 
  • Management of revisions or clarifications requested by scientific committees 
  • Tracking of acceptance notifications and key deadlines 
  • Support with next steps: poster, oral presentation, slides, publication 

End-to-End Digital Workflow Via the MphaR Platform:

For teams seeking streamlined, centralized collaboration, our MphaR Digital Platform enables:
  • Real-time or asynchronous review
  • Commenting and version control
  • Secure data sharing
  • Faster consensus and approvals
  • Compliance-ready documentation

Examples of Consensus & Publication Projects

Breast Cancer

Unprecedented responses to neo adjuvant sequential administration of Tocilizumab followed by cisplatin/docetaxel for locally advanced triple negative breast cancer patients
Taher Al-Tweigeri et al.
Cancer Res (2024) 84 (9_Supplement): PO3-25-11.

Chronic Lymphocytic Leukemia

An international view on the current approaches to frontline chronic lymphocytic leukemia therapy​
Guilherme Perini et al.​
Blood (2025) 146 (Supplement 1): 7937.​

Chronic Lymphocytic Leukaemia​

Patient perspectives on CLL treatment side effects: A sub-analysis of the VOICE survey.​Implementing precision oncology in Latin America to improve patient outcomes
Constantine Tam et al.​
J Clin Oncol 41, 7534(2023)

Chronic Lymphocytic Leukaemia​

Patient perspectives on CLL treatment side effects: A sub-analysis of the VOICE survey.​Lung Cancer Screening in Asia: An Expert Consensus Report
Constantine Tam et al.​
HemaSphere 7(S3):p e9384994, August 2023.

Benefits of Partnering With MphaR

Expertise in global congresses & therapeutic areas

Experience across oncology, hematology, immunology, rare diseases, cardiovascular, and more.

Faster turnaround & deadline-driven delivery

We manage tight timelines and ensure readiness well before submission windows close.

Cross-functional alignment

Seamless collaboration with Medical Affairs, Clinical, HEOR, and Market Access teams.

High scientific quality

Accurate interpretation, strong narrative development, and publication-grade writing.

Support across the full publication lifecycle

From abstract → poster/oral presentation → manuscript.

Transforming Published Evidence Into Clear, Actionable Insights

At MphaR, we conduct high-quality literature reviews and systematic reviews that help pharmaceutical, biotech, and medical device companies make informed, evidence-based decisions. Our rigorous and transparent approach ensures that you receive a comprehensive understanding of the scientific landscape—whether to support medical strategy, identify evidence gaps, inform clinical development, or prepare for regulatory, market access, and Medical Affairs activities.
Our team combines scientific expertise, advanced search strategies, and digital tools to deliver reliable, well-structured, and publication-ready outputs.

Our Review Services Include

1. Targeted Literature Reviews (TLRs)

Designed to answer specific scientific or clinical questions with focused, efficient searches.
We provide:
  • Precise search strategies tailored to your objectives
  • Screening of abstracts and full texts
  • Extraction of key findings and insights
  • Gap analysis and competitive landscape overview
  • Clear, decision-support summaries

Ideal for medical strategy planning, advisory boards, and evidence-based messaging.

2. Systematic Literature Reviews (SLRs)

A structured, reproducible method following PRISMA and industry best practices.

Our SLRs include:

  • Protocol development (PICO, eligibility criteria)
  • Multi-database searches (PubMed, Embase, Cochrane, others)
  • Double screening & quality assessment
  • Data extraction and standardized evidence tables
  • Statistical synthesis (optional)
  • PRISMA diagrams and structured reporting
These reviews form a solid scientific foundation for HTA submissions, global value dossiers, RWE strategies, and peer-reviewed publications.

3. Evidence Gap Analysis & Insights Mapping

We identify unmet needs, inconsistencies, and research opportunities in the existing body of knowledge.
Deliverables include:
  • Evidence heatmaps
  • Clinical pathway insights
  • Competitor landscape
  • Strategic recommendations for evidence generation

4. Rapid Reviews

A faster approach when timelines are tight—maintaining methodological rigor while accelerating delivery.

Perfect for launch readiness, congress preparation, or urgent internal decision-makin

Key Deliverables

  • Executive summary & key takeaways
  • Detailed evidence tables 
  • PRISMA flow diagram
  • Thematic analysis & visual insights
  • Strategic interpretation aligned with your objectives
  • Optional: slide deck for internal use or advisory boards
  • Optional: manuscript development for peer-reviewed publication

Powered by the MphaR Digital Platform

A centralized virtual environment for:
  • Sharing and reviewing references
  • Collaborative annotations
  • Asynchronous discussions
  • Real-time progress tracking
This enhances transparency, speeds up review cycles, and improves alignment across stakeholders.

Benefits of Partnering With MphaR

 Rigorous, compliant methodologies (PRISMA, Cochrane, GPP)

Ensuring transparency, reproducibility, and scientific credibility.

Cross-functional relevance

Insights tailored for Medical Affairs, Clinical Development, HEOR, Market Access, and Commercial teams.

High scientific quality

Experienced PhD/MD-level reviewers and medical writers.

Global search capabilities

Access to all major biomedical databases and grey literature sources.

Digital collaboration

Reviews can be conducted fully on the MphaR Digital Platform, enabling real-time tracking, commenting, version control, and secure data sharing.

What HCPs and Medical Affairs Experts Tell About Working with Us

We work closely with HCPs and Medical Affairs experts worldwide. Here’s what they share about partnering with MphaR

Trusted by Leading Brands

Medical Affairs Trends: Blog, Digest and Podcasts

Stay informed on emerging Medical Affairs trends with expert blog articles, and twice-monthly editions of our Medical Affairs Digest and podcasts series.

TrendWatch: Medical Affairs

Explore concise articles covering the latest trends and innovations in Medical Affairs

Latest Article

Virtual Reality in Medical Training: Immersive Learning Experiences

Contemporary medical education faces limitations in clinical exposure and resources, but virtual reality (VR) has emerged as a powerful solution. By recreating realistic and interactive clinical environments, VR allows healthcare professionals to actively engage in simulated experiences, enhancing skill refinement in a safe and scalable manner. Ultimately, this immersive technology promises profound improvements in training quality, competency development, and patient safety.

Sustainability in the Pharmaceutical Industry: A Greener Future for Healthcare

This blog post examines the environmental impact of the pharmaceutical industry, including high energy consumption and waste generation. It emphasizes the urgent need for sustainable practices, such as energy efficiency measures, water conservation, and waste reduction, to minimize environmental harm and ensure the industry’s long-term viability.

The Best Icebreakers for Virtual Meetings

The healthcare industry implemented different techniques to make interactions between pharmaceutical companies, healthcare professionals, and general physicians. Icebreakers for virtual meetings make it easy to connect with simple activities to build team camaraderie.

Bi-monthly Newsletter: Medical Affairs Digest

Your bi-monthly overview of essential Medical Affairs updates and emerging industry signals

Latest Newsletter
Bi-Monthly podcasts: Medical Affairs Voices

Listen to expert conversations exploring current trends and future directions in Medical Affairs

Precision Medicine in Oncology: Transforming Cancer Diagnostics Using AI Tools

In this episode, we uncover how artificial intelligence is transforming oncology, marking a shift from standardizedtreatments to precision medicine tailored to each patient’s genetic and molecular profile. From AI-powered imaging and digital pathology to genomic analysis and liquid biopsies, technology is reshaping how cancer is detected, understood, and treated. Hear how these innovations are driving earlier diagnoses, improving treatment accuracy, and empowering clinicians with insights once thought impossible. We also explore the ethical and practical challenges of integrating AI into cancercare and what it means for patients and providers alike. Join us as we look ahead to a future where AI doesn’t replace the human touch—it amplifies it, bringing us closer to truly personalized oncology care.

Leveraging AI and NLP to Transform Medical Information Systems in Medical Affairs

In this episode, we explore how artificial intelligence and natural language processing are reshaping how Medical Affairs teams manage, interpret, and apply vast volumes of unstructured medical information. From scientific literature and safety reports to advisory board insights and field intelligence, NLP is turning free text into structured, actionable knowledge—helping teams move faster while maintaining scientific rigor. Discover how NLP is being applied across literature intelligence, medical information systems, pharmacovigilance, and stakeholder engagement, and why human oversight remains essential in regulated medical environments. We also examine the risks, ethical considerations, and governance frameworks needed to ensure accuracy, transparency, and compliance. Join us as we look ahead to the evolution from language processing to true language understanding—and what this shift means for the future of Medical Affairs as a strategic, insight-driven function.

From Data to Dialogue — Strengthening Patient-Centricity Through Virtual Advisory Boards

In this episode, we examine how Virtual Advisory Boards are revolutionizing patient engagement, turning static data into meaningful dialogue that shapes real-world decisions. As patient-centricity becomes a defining principle in modern pharma, digital platforms are creating space for authentic collaboration between patients, caregivers, and industry leaders. Discover how virtual formats remove barriers to participation, ensure inclusivity, and make continuous patient input a practical reality. We’ll explore how the MphaR Virtual Advisory Board platform enables companies to integrate patient insights into trial design, treatment strategies, and beyond. Tune in as we explore how the future of patient engagement is being built—one conversation at a time—through innovation, empathy, and dialogue that truly puts patients at the center of healthcare.

Follow MphaR on Social Media:

FAQs

Yes. We coordinate expert groups, facilitate discussions, draft documents, and manage revisions until publication.
Yes. We work closely with your teams and experts to develop publication-ready content based on available evidence.
Yes. We handle submission, formatting, responses to reviewers, and follow-up communication with journals.
×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure